Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230671 | 12723067 | 1 | I | 20160902 | 20160908 | 20160908 | EXP | CA-AMGEN-CANSP2016118438 | AMGEN | 59.00 | YR | A | F | Y | 0.00000 | 20160907 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230671 | 12723067 | 1 | PS | filgrastim | FILGRASTIM | 1 | Subcutaneous | 300 MUG, QD | U | 103353 | 300 | UG | UNKNOWN FORMULATION | QD | |||||
| 127230671 | 12723067 | 2 | SS | OBINUTUZUMAB | OBINUTUZUMAB | 1 | Intravenous (not otherwise specified) | 975 MG, UNK | 0 | 975 | MG | SOLUTION FOR INFUSION | |||||||
| 127230671 | 12723067 | 3 | SS | OBINUTUZUMAB | OBINUTUZUMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | SOLUTION FOR INFUSION | |||||||||
| 127230671 | 12723067 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 250 MG/M2, UNK | 0 | 250 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 250 MG/M2, UNK | 0 | 250 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 250 MG/M2, UNK | 0 | 250 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 7 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 25 MG/M2, UNK | 0 | 25 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 8 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 25 MG/M2, UNK | 0 | 25 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 9 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 25 MG/M2, UNK | 0 | 25 | MG/M**2 | ||||||||
| 127230671 | 12723067 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 650 MG, UNK | 0 | 650 | MG | ||||||||
| 127230671 | 12723067 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | |||||||||||
| 127230671 | 12723067 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNK | 0 | ||||||||||
| 127230671 | 12723067 | 13 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 127230671 | 12723067 | 14 | C | DEMEROL | MEPERIDINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 50 MG, UNK | 0 | 50 | MG | ||||||||
| 127230671 | 12723067 | 15 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 8 MG, UNK | 0 | 8 | MG | ||||||||
| 127230671 | 12723067 | 16 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 127230671 | 12723067 | 17 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 127230671 | 12723067 | 18 | C | FUROSEMIDE SODIUM | FUROSEMIDE SODIUM | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 127230671 | 12723067 | 19 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 127230671 | 12723067 | 20 | C | RED BLOOD CELLS | HUMAN RED BLOOD CELL | 1 | Intravenous (not otherwise specified) | 2 DF, UNK | 0 | 2 | DF | ||||||||
| 127230671 | 12723067 | 21 | C | SEPTRA | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127230671 | 12723067 | 1 | Product used for unknown indication |
| 127230671 | 12723067 | 2 | Chronic lymphocytic leukaemia |
| 127230671 | 12723067 | 4 | Chronic lymphocytic leukaemia |
| 127230671 | 12723067 | 7 | Chronic lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127230671 | 12723067 | OT |
| 127230671 | 12723067 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127230671 | 12723067 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |